Rosetta Genomics (ROSG) Reports Q4 Loss Per Share of $0.14

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/12/2026

1. MIRM
2. SPY
3. META
4. MSFT
5. PLTR
6. JNJ
7. LDOS
8. HUM
9. CSCO
10. KTOS

Go back to Rosetta Genomics (ROSG) Reports Q4 Loss Per Share of $0.14

Rosetta Genomics Reports 2015 Full Year Financial Results

March 23, 2016 4:05 PM EDT

Revenues reach a record $3.6 million for the fourth quarter, $10.2 million (pro forma) for the year

Conference call begins today at 5:00 p.m. Eastern time

PHILADELPHIA & REHOVOT, Israel--(BUSINESS WIRE)-- Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based and other molecular diagnostics, today reported financial results for the 12 months ended December 31, 2015.

Recent developments include:

Launched RosettaGX Reveal, a first-of-its-kind, microRNA-based indeterminate thyroid nodule classification assay, at the International Thyroid Congress and Annual Meeting of the American Thyroid Association;... More